{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:53:49Z","timestamp":1790103229146,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T00:00:00Z","timestamp":1620432000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T00:00:00Z","timestamp":1620432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Female sexual partners of men who inject drugs (MWID) living with HIV are at risk of HIV transmission. HIV prevalence estimates among non-drug using female sex partners of MWID are scarce, with no studies documenting HIV incidence. We investigated HIV prevalence and incidence among female spouses of MWID registered at Nai Zindagi Trust (NZT), Pakistan, between 2012 and 2019.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>NZT registration and service provision data for female spouses who participated in HIV testing and counselling calculated HIV prevalence and incidence using the person years (PY) method. Cox proportional hazards models identified factors associated with incident infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Overall HIV prevalence among female spouses of MWID was 8.5%. Among 3478 HIV-negative female spouses, 109 incident infections were observed, yielding an incidence rate of 1.5\/100PY (95% CI 1.2\u20131.8). Independent predictors of incident infection were registration in Punjab province (AHR 1.73 95% CI 1.13\u20132.68,<jats:italic>p<\/jats:italic>\u2009=\u20090.012) and 1\u20135\u00a0years of education (AHR 1.89 95% CI 1.22\u20132.93,<jats:italic>p<\/jats:italic>\u2009=\u20090.004). Knowledge of HIV at registration was protective against infection (AHR 0.51, 95% CI 0.26\u20130.99,<jats:italic>p<\/jats:italic>\u2009=\u20090.047), along with a MWID spouse who had initiated antiretroviral therapy (ART) (AHR 0.25, 95% CI 0.16\u20130.38,<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), while incident infection was inversely associated with number of children (\u2265\u20095 children AHR 0.44 95% CI 0.22\u20130.88,<jats:italic>p<\/jats:italic>\u2009=\u20090.022).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Additional efforts are needed to reduce HIV transmission among female spouses of MWID, including targeted provision of HIV education and access to HIV screening. Interventions that target MWID are also required, including evidence-based drug treatment and access to ART, including support to maximize adherence. Finally, consideration should be given to making HIV pre-exposure prophylaxis available to female spouses at high risk of HIV transmission, particularly young women and those whose husbands are not receiving, or have difficulty adhering to, ART.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12954-021-00497-1","type":"journal-article","created":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T12:02:57Z","timestamp":1620475377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["HIV incidence and associated risk factors in female spouses of men who inject drugs in Pakistan"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0062-7300","authenticated-orcid":false,"given":"Jenny","family":"Iversen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"ul H Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malika","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Machteld","family":"Busz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,8]]},"reference":[{"issue":"12","key":"497_CR1","doi-asserted-by":"publisher","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","volume":"5","author":"L Degenhardt","year":"2017","unstructured":"Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;5(12):e1192\u2013207.","journal-title":"Lancet Glob Health"},{"key":"497_CR2","unstructured":"National AIDS Control Program. National AIDS Control Program 2016\/17 Integrated Biological and Behavioural Surveillance. Islamabad, Pakistan; 2017."},{"key":"497_CR3","unstructured":"Nai Zindagi Trust. Data highlights, updated 30 June 2019. https:\/\/www.naizindagi.org\/. Islamabad, Pakistan; Accessed 8 Oct 2019."},{"key":"497_CR4","unstructured":"UNAIDS. UNAIDS DATA 2020. Geneva, Switzerland.: Joint United Nations Programme on HIV\/AIDS. Available at https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2020_aids-data-book_en.pdf. Accessed 5 Nov 2020."},{"issue":"7","key":"497_CR5","doi-asserted-by":"publisher","first-page":"e418","DOI":"10.1016\/S2352-3018(19)30179-1","volume":"6","author":"A Ahmed","year":"2019","unstructured":"Ahmed A, Hashmi FK, Khan GM. HIV outbreaks in Pakistan Lancet HIV. 2019;6(7):e418.","journal-title":"HIV outbreaks in Pakistan Lancet HIV"},{"issue":"7","key":"497_CR6","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1473-3099(19)30316-0","volume":"19","author":"TLI Diseases","year":"2019","unstructured":"Diseases TLI. HIV epidemics in Pakistan. Lancet Infect Dis. 2019;19(7):671.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"497_CR7","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1111\/tbed.13621","volume":"67","author":"AF Kabapy","year":"2020","unstructured":"Kabapy AF, Shatat HZ, Abd El-Wahab EW. Attributes of HIV infection over decades (1982\u20132018): A systematic review and meta-analysis. Transbound Emerg Dis. 2020;67(6):2372\u201388.","journal-title":"Transbound Emerg Dis"},{"issue":"10","key":"497_CR8","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1097\/QAD.0000000000000298","volume":"28","author":"P Patel","year":"2014","unstructured":"Patel P, Borkowf CB, Brooks JT, Lasry A, Lansky A, Mermin J. Estimating per-act HIV transmission risk: a systematic review. AIDS. 2014;28(10):1509\u201319.","journal-title":"AIDS"},{"issue":"3","key":"497_CR9","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s10461-011-0078-9","volume":"17","author":"A Uuskula","year":"2013","unstructured":"Uuskula A, McMahon JM, Kals M, Talu A, Abel-Ollo K, Ruutel K, et al. Risk for heterosexual HIV transmission among non-injecting female partners of injection drug users in Estonia. AIDS Behav. 2013;17(3):879\u201388.","journal-title":"AIDS Behav"},{"issue":"7","key":"497_CR10","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1258\/0956462001916137","volume":"11","author":"S Panda","year":"2000","unstructured":"Panda S, Chatterjee A, Bhattacharya SK, Manna B, Singh PN, Sarkar S, et al. Transmission of HIV from injecting drug users to their wives in India. Int J STD AIDS. 2000;11(7):468\u201373.","journal-title":"Int J STD AIDS"},{"issue":"1","key":"497_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/01.qai.0000160713.94203.9b","volume":"39","author":"S Panda","year":"2005","unstructured":"Panda S, Kumar MS, Lokabiraman S, Jayashree K, Satagopan MC, Solomon S, et al. Risk factors for HIV infection in injection drug users and evidence for onward transmission of HIV to their sexual partners in Chennai, India. J Acquir Immune Defic Syndr. 2005;39(1):9\u201315.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 1","key":"497_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11524-009-9369-0","volume":"86","author":"LM Niccolai","year":"2009","unstructured":"Niccolai LM, Shcherbakova IS, Toussova OV, Kozlov AP, Heimer R. The potential for bridging of HIV transmission in the Russian Federation: sex risk behaviors and HIV prevalence among drug users (DUs) and their non-DU sex partners. J Urban Health. 2009;86(Suppl 1):131\u201343.","journal-title":"J Urban Health"},{"issue":"4","key":"497_CR13","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1080\/07399332.2017.1423315","volume":"39","author":"V Do","year":"2018","unstructured":"Do V, Ho H, Nguyen T, Do H. Sexual violence and the risk of HIV transmission in sexual partners of male injecting drug users in Tien Du district, Bac Ninh province of Vietnam. Health Care Women Int. 2018;39(4):404\u201314.","journal-title":"Health Care Women Int"},{"issue":"Suppl 1","key":"497_CR14","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1097\/COH.0000000000000263","volume":"11","author":"S Shahid","year":"2016","unstructured":"Shahid S, Majeed MF, Awaan AB, Mirza H, Sarfraz N, Veronese V. Expanding access to HIV testing and counseling and exploring vulnerabilities among spouses of HIV-positive men who inject drugs in Pakistan. Curr Opin HIV AIDS. 2016;11(Suppl 1):S6-12.","journal-title":"Curr Opin HIV AIDS"},{"issue":"6","key":"497_CR15","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.drugpo.2013.11.009","volume":"25","author":"N El-Bassel","year":"2014","unstructured":"El-Bassel N, Gilbert L, Terlikbayeva A, Beyrer C, Wu E, Shaw SA, et al. HIV risks among injecting and non-injecting female partners of men who inject drugs in Almaty, Kazakhstan: implications for HIV prevention, research, and policy. Int J Drug Policy. 2014;25(6):1195\u2013203.","journal-title":"Int J Drug Policy"},{"issue":"Suppl 3","key":"497_CR16","doi-asserted-by":"crossref","first-page":"e25317","DOI":"10.1002\/jia2.25317","volume":"22","author":"M Malik","year":"2019","unstructured":"Malik M, Jamil MS, Johnson CC, Pasha MS, Hermez J, Qureshi SUH. Integrating assisted partner notification within HIV prevention service package for people who inject drugs in Pakistan. J Int AIDS Soc. 2019;22(Suppl 3):e25317.","journal-title":"J Int AIDS Soc"},{"key":"497_CR17","doi-asserted-by":"crossref","unstructured":"Alipour A, Haghdoost AA, Sajadi L, Zolala F. HIV prevalence and related risk behaviours among female partners of male injecting drugs users in Iran: results of a bio-behavioural survey, 2010. Sex Transm Infect. 2013;89 Suppl 3:iii41\u20134.","DOI":"10.1136\/sextrans-2013-051201"},{"key":"497_CR18","first-page":"189","volume":"111","author":"S Chakrabarti","year":"2000","unstructured":"Chakrabarti S, Panda S, Chatterjee A, Sarkar S, Manna B, Singh NB, et al. HIV-1 subtypes in injecting drug users and their non-injecting wives in Manipur, India. Indian J Med Res. 2000;111:189\u201394.","journal-title":"Indian J Med Res"},{"key":"497_CR19","unstructured":"National AIDS Control Program. AIDS Epidemic Modelling Exercise For Pakistan 2017. Islamabad, Pakistan; 2017."},{"key":"497_CR20","unstructured":"National Institute of Population Studies Pakistan and ICF. Pakistan Demographic and Health Survey 2017\u201318. Islamabad, Pakistan, and Rockville, Maryland, USA: NIPS and ICF; 2019."},{"key":"497_CR21","first-page":"CD001224","volume":"9","author":"VA Fonner","year":"2012","unstructured":"Fonner VA, Denison J, Kennedy CE, O\u2019Reilly K, Sweat M. Voluntary counseling and testing (VCT) for changing HIV-related risk behavior in developing countries. Cochrane Database Syst Rev. 2012;9:CD001224.","journal-title":"Cochrane Database Syst Rev."},{"issue":"4","key":"497_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.26719\/2011.17.4.271","volume":"17","author":"S Ahmad","year":"2011","unstructured":"Ahmad S, Mehmood J, Awan AB, Zafar ST, Khoshnood K, Khan AA. Female spouses of injection drug users in Pakistan: a bridge population of the HIV epidemic? East Mediterr Health J. 2011;17(4):271\u20136.","journal-title":"East Mediterr Health J"},{"issue":"2","key":"497_CR23","first-page":"26","volume":"14","author":"MZ Zakar","year":"2013","unstructured":"Zakar MZ, Quereshi S, Zakar R, Rana S. Unsafe injection practices and transmission risk of infectious diseases in pakistan: Perspectives and practices. Pakistan Vision. 2013;14(2):26\u201350.","journal-title":"Pakistan Vision"},{"issue":"7","key":"497_CR24","doi-asserted-by":"publisher","first-page":"e418","DOI":"10.1016\/S2352-3018(19)30180-8","volume":"6","author":"M Zaid","year":"2019","unstructured":"Zaid M, Ali M, Afzal MS. HIV outbreaks in Pakistan. Lancet HIV. 2019;6(7):e418\u20139.","journal-title":"Lancet HIV"},{"issue":"2","key":"497_CR25","doi-asserted-by":"publisher","first-page":"e55747","DOI":"10.1371\/journal.pone.0055747","volume":"8","author":"MR Loutfy","year":"2013","unstructured":"Loutfy MR, Wu W, Letchumanan M, Bondy L, Antoniou T, Margolese S, et al. Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy. PLoS ONE. 2013;8(2):e55747.","journal-title":"PLoS ONE"},{"issue":"3","key":"497_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.26719\/2018.24.3.237","volume":"24","author":"B Ali","year":"2018","unstructured":"Ali B, Nisar N, Nawab F. Adherence to antiretroviral therapy in HIV-positive, male intravenous drug users in Pakistan. East Mediterr Health J. 2018;24(3):237\u201342.","journal-title":"East Mediterr Health J"},{"issue":"6","key":"497_CR27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa1105243","volume":"365","author":"MS Cohen","year":"2011","unstructured":"Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493\u2013505.","journal-title":"N Engl J Med"},{"issue":"12","key":"497_CR28","doi-asserted-by":"publisher","first-page":"e678","DOI":"10.1016\/S2352-3018(18)30252-2","volume":"5","author":"A Altaf","year":"2018","unstructured":"Altaf A. Delays and gaps in HIV programmes in Pakistan. Lancet HIV. 2018;5(12):e678\u20139.","journal-title":"Lancet HIV"},{"issue":"4","key":"497_CR29","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/COH.0b013e3283536ab2","volume":"7","author":"N El-Bassel","year":"2012","unstructured":"El-Bassel N, Wechsberg WM, Shaw SA. Dual HIV risk and vulnerabilities among women who use or inject drugs: no single prevention strategy is the answer. Curr Opin HIV AIDS. 2012;7(4):326\u201331.","journal-title":"Curr Opin HIV AIDS"},{"issue":"Suppl 2","key":"497_CR30","doi-asserted-by":"publisher","first-page":"S128","DOI":"10.1097\/QAI.0000000000000627","volume":"69","author":"WM Wechsberg","year":"2015","unstructured":"Wechsberg WM, Deren S, Myers B, Kirtadze I, Zule WA, Howard B, et al. Gender-specific HIV prevention interventions for women who use alcohol and other drugs: the evolution of the science and future directions. J Acquir Immune Defic Syndr. 2015;69(Suppl 2):S128\u201339.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 2","key":"497_CR31","doi-asserted-by":"publisher","first-page":"S176","DOI":"10.1097\/QAI.0000000000000659","volume":"69","author":"J Iversen","year":"2015","unstructured":"Iversen J, Page K, Madden A, Maher L. HIV, HCV, and health-related harms among women who inject drugs: implications for prevention and treatment. J Acquir Immune Defic Syndr. 2015;69(Suppl 2):S176\u201381.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"497_CR32","first-page":"CD004145","volume":"8","author":"L Gowing","year":"2011","unstructured":"Gowing L, Farrell MF, Bornemann R, Sullivan LE, Ali R. Oral substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev. 2011;8:CD004145.","journal-title":"Cochrane Database Syst Rev."}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-021-00497-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-021-00497-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-021-00497-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T12:42:28Z","timestamp":1699015348000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-021-00497-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,8]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["497"],"URL":"https:\/\/doi.org\/10.1186\/s12954-021-00497-1","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,8]]},"assertion":[{"value":"16 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board at NZT granted ethical approval for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors have any conflict of interest to declare<b>.<\/b>","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}